Discordance in the presumptive etiologic diagnosis and amyloid burden by ethnoracial status

These results add to a growing literature examining amyloid biomarkers across racial and ethnic groups. A limitation of this study is the small sample sizes in several of the groups analyzed. Further research is needed to assess these observed potential differences and the implications to AD trial eligibility and treatment.